SERAQUIN Tablets

SECTION 2: Hazards identification

OSHA Regulatory Status Emergency Overview Physical State: Cats and small dogs: 800 mg tablet Convex chewable tablet (12 mm diameter; height 7 mm) SERAQUIN is presented in a box with 3 blisters (strips) of 20 tablets. Boehringer Ingelheim name, logo and SERAQUIN are printed in black on the back of the aluminum foil. Dogs: 2 gram tablet Convex chewable tablet (19 mm diameter; height 7 mm) SERAQUIN is presented in a box with 3 or 6 blisters (strips) of 10 tablets. Boehringer Ingelheim name, logo and SERAQUIN are printed in black on the back of the aluminum foil. Color: Light beige with orange spots Odor: Sour yeast and cheese Not classified as hazardous. Handle in accordance with good industrial hygiene and safety practice. For cats and dogs - oral use only. Not for human use.

Precautionary statements

Keep out of reach of children. Keep only in original container. Avoid direct sunlight and moisture. Keep at a temperature not exceeding 30° C. If medical advice is needed: Have product container or label at hand. Fire-fighting: Use foam, carbon dioxide, dry powder and water fog or material appropriate for surrounding fire. Wash thoroughly with soap and water after handling. Spills: Sweep spilled substance into appropriate waste containers. If swallowed, seek medical advice and show this container or label. Keep away from food, drink, and animal feedstuffs. Acute effect: Improved joint function in the animal. Precautions/Contraindications: Use with caution in animals with a history of clotting disorders, diabetes, metabolic disorders associated with hyperglycemia, urinary tract stones and allergies to shellfish. Overdosage: None known ADVERSE REACTIONS TO PRODUCT: If the animal’s condition worsens or does not improve, stop product immediately and consult your veterinarian.

Potential health effects

Inhalation: Not expected to be an inhalation hazard. Eye Contact: Not expected to be a hazard to the eye with prescribed use. Contact with eye may cause transient irritation. Skin Contact: Not expected to be a skin hazard. Can cause hypersensitive reactions for patients allergic to any of the components or shell fish. Ingestion: Not expected to be an ingestion hazard.

Potential chronic health

Possible hypersensitization (development of abnormal sensitivity to shellfish). Target Organ(s): Bones/joints Potential Physical Effects: Improved joint function OSHA Regulatory Status: Nonhazardous, exempt

Environmental hazards

No data available